Nadir creatinine as a predictor of renal outcomes in PUVs: A systematic review and meta-analysis.
chronic kidney disease
nadir creatinine
posterior urethral valve (PUV)
posterior urethral valves
predictive factor
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2023
2023
Historique:
received:
31
10
2022
accepted:
16
02
2023
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
Posterior urethral valves (PUVs) represent the most severe pediatric obstructive uropathy, responsible for chronic renal failure in up to 65% of cases and progression to end-stage kidney disease (ESKD) in about 8%-21% of patients. Unfortunately, renal outcomes have poorly improved over time. The key point is to identify patients at risk; thus, several prenatal and postnatal prognostic factors have been analyzed to improve clinical outcomes. Postnatal nadir creatinine seems to accurately predict long-term renal prognosis, but there is no definitive evidence to support this finding. We performed a systematic review with meta-analysis to analyze the predictive value of nadir creatinine on long-term renal function in infants with PUVs. We conducted this systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed and Cochrane Library were systematically searched for studies published from January 2008 to June 2022. All the articles were checked independently by two reviewers in two steps. A total of 24 articles were screened, and 13 were included for data extraction. Data from 1,731 patients with PUVs were analyzed, with a mean follow-up of 5.5 years; of these, on average, 37.9% developed chronic kidney disease (CKD) and 13.6% developed ESKD. All the articles evaluated nadir creatinine as a predictor of CKD, most using a level of 1 mg/dL, with statistical significance at the 5% level. The relative risk of developing CKD in patients with creatinine values higher than the nadir cutoff considered was 7.69 (95% CI: 2.35-25.17, Nadir creatinine is the best prognostic factor for long-term renal function in patients affected by PUV. A value above the cutoff of 1 mg/dL should be considered a significant predictor for the risk of CKD and ESKD. Further studies are needed to define different nadir creatinine cutoffs for better stratification of the different CKD stages and for the development of reliable scores, which include the association of several variables.
Sections du résumé
Background
UNASSIGNED
Posterior urethral valves (PUVs) represent the most severe pediatric obstructive uropathy, responsible for chronic renal failure in up to 65% of cases and progression to end-stage kidney disease (ESKD) in about 8%-21% of patients. Unfortunately, renal outcomes have poorly improved over time. The key point is to identify patients at risk; thus, several prenatal and postnatal prognostic factors have been analyzed to improve clinical outcomes. Postnatal nadir creatinine seems to accurately predict long-term renal prognosis, but there is no definitive evidence to support this finding.
Objective
UNASSIGNED
We performed a systematic review with meta-analysis to analyze the predictive value of nadir creatinine on long-term renal function in infants with PUVs.
Methods
UNASSIGNED
We conducted this systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed and Cochrane Library were systematically searched for studies published from January 2008 to June 2022. All the articles were checked independently by two reviewers in two steps.
Results
UNASSIGNED
A total of 24 articles were screened, and 13 were included for data extraction. Data from 1,731 patients with PUVs were analyzed, with a mean follow-up of 5.5 years; of these, on average, 37.9% developed chronic kidney disease (CKD) and 13.6% developed ESKD. All the articles evaluated nadir creatinine as a predictor of CKD, most using a level of 1 mg/dL, with statistical significance at the 5% level. The relative risk of developing CKD in patients with creatinine values higher than the nadir cutoff considered was 7.69 (95% CI: 2.35-25.17,
Conclusions
UNASSIGNED
Nadir creatinine is the best prognostic factor for long-term renal function in patients affected by PUV. A value above the cutoff of 1 mg/dL should be considered a significant predictor for the risk of CKD and ESKD. Further studies are needed to define different nadir creatinine cutoffs for better stratification of the different CKD stages and for the development of reliable scores, which include the association of several variables.
Identifiants
pubmed: 37009274
doi: 10.3389/fped.2023.1085143
pmc: PMC10050680
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1085143Informations de copyright
© 2023 Meneghesso, Bertazza Partigiani, Spagnol, Brazzale, Morlacco and Vidal.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Open Med. 2009;3(3):e123-30
pubmed: 21603045
J Urol. 2008 Oct;180(4 Suppl):1705-8; discussion 1708
pubmed: 18708224
Pediatr Res. 2014 Dec;76(6):560-3
pubmed: 25198372
Adv Clin Exp Med. 2017 Nov;26(8):1293-1300
pubmed: 29264889
J Urol. 2011 Jun;185(6 Suppl):2491-5
pubmed: 21555022
J Pediatr Surg. 2019 Feb;54(2):318-321
pubmed: 30528204
PLoS One. 2012;7(9):e44663
pubmed: 23028576
Cir Pediatr. 2022 Oct 01;35(4):180-186
pubmed: 36217788
J Pediatr Urol. 2016 Aug;12(4):227.e1-7
pubmed: 27160979
J Pediatr Surg. 2022 Nov;57(11):690-695
pubmed: 35101262
Nat Rev Urol. 2022 May;19(5):295-303
pubmed: 35136187
J Indian Assoc Pediatr Surg. 2020 Jul-Aug;25(4):219-224
pubmed: 32939113
J Proteomics. 2018 Jul 30;184:1-9
pubmed: 29929039
J Pediatr Urol. 2016 Jun;12(3):179.e1-7
pubmed: 26705688
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Int J Urol. 2008 Mar;15(3):235-40
pubmed: 18304219
J Matern Fetal Neonatal Med. 2015 Jun;28(9):1026-31
pubmed: 25000449
Biomedicines. 2022 Aug 05;10(8):
pubmed: 36009441
J Pediatr Urol. 2016 Feb;12(1):2-4
pubmed: 26921022
Pediatr Surg Int. 2022 Sep;38(9):1321-1326
pubmed: 35779105
J Pediatr Urol. 2022 Dec;18(6):813-819
pubmed: 35840456
J Pediatr Urol. 2015 Aug;11(4):214.e1-3
pubmed: 26062970
J Urol. 2016 Sep;196(3):862-8
pubmed: 27017936
J Urol. 2008 Jan;179(1):307-12; discussion 312-3
pubmed: 18006017
Pediatrics. 2019 Mar;143(3):
pubmed: 30709926
Am J Epidemiol. 2018 Apr 1;187(4):864-870
pubmed: 29020135
Res Rep Urol. 2021 Sep 01;13:639-645
pubmed: 34513741
Curr Med Chem. 2023;30(15):1712-1735
pubmed: 35927803
J Urol. 2006 Apr;175(4):1214-20
pubmed: 16515962
Semin Fetal Neonatal Med. 2007 Dec;12(6):464-70
pubmed: 17761463
J Pediatr Urol. 2010 Jun;6(3):261-4
pubmed: 19833558
Sci Transl Med. 2013 Aug 14;5(198):198ra106
pubmed: 23946195
Prenat Diagn. 2017 Sep;37(9):931-934
pubmed: 28753736
Pediatr Nephrol. 2018 Oct;33(10):1651-1661
pubmed: 29159472
Curr Urol Rep. 2001 Apr;2(2):138-45
pubmed: 12084283
Pediatr Nephrol. 2021 Jul;36(7):1817-1824
pubmed: 33462698
Pediatr Nephrol. 2016 Sep;31(9):1411-20
pubmed: 26667236
BMC Urol. 2018 May 21;18(1):46
pubmed: 29783971
Pediatr Nephrol. 2022 Jun;37(6):1339-1345
pubmed: 34716802
J Pediatr Urol. 2015 Dec;11(6):356.e1-5
pubmed: 26292912
ScientificWorldJournal. 2009 Oct 14;9:1119-26
pubmed: 19838598
Pediatr Nephrol. 2019 Feb;34(2):283-294
pubmed: 30196383
J Perinatol. 2020 Jan;40(1):112-117
pubmed: 31471579
Urol Int. 2004;73(4):296-301
pubmed: 15604570
Rays. 2002 Apr-Jun;27(2):131-4
pubmed: 12696266